mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |